Volume 6, Issue 2 (6-2018)
Jorjani Biomed J 2018, 6(2): 21-32 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Haj Mohammadi Z, Abolmaali S, Akbarzadeh A. Preparing Nanoarchaeosome Containing Triptorelin Acetate and Evaluation of Its Cellular Toxic Effect on PC3 Prostate Cancer Cell Line. Jorjani Biomed J 2018; 6 (2) :21-32
URL: http://goums.ac.ir/jorjanijournal/article-1-610-en.html
URL: http://goums.ac.ir/jorjanijournal/article-1-610-en.html
1- Faculty of Biotechnology Department for Microbial biotechnology, Semnan University, Semnan, Iran
2- Pasteur Institute of Iran, Tehran, Iran. , azimakbarzadehkhyavi@yahoo.com
2- Pasteur Institute of Iran, Tehran, Iran. , azimakbarzadehkhyavi@yahoo.com
Abstract: (7641 Views)
Background and objectives: Prostate cancer is the second leading cause of mortality among men worldwide, and the eighth cancer-related cause of death in Iran. Male sex hormones (androgens) are the main cause of prostate cancer cells. Triptorelin is considered a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) in the treatment of prostate cancer. This study aimed to evaluate the methods to deal with the constraints in use of lipid nanoarchaeosomes. Due to their adjuvant feature and presence of ether links, archaeosomes are more stable in blood, compared to other lipid-based formulations. In the present study, the effects of nanoarchaeosomes containing triptorelin acetate on the cellular toxicity of the PC3 prostate cancer cell line were evaluated.
Methods: Halobacterium salinarum bacteria were cultured in HS medium, and their polar lipids of the membrane were removed applying the Blight&Dye technique in order to obtain nanoarchaeosome containing membrane polar lipids. In the next stage, nanoarchaeosomes were prepared by the hydration of polar lipids. In addition, cell viability was evaluated using the MTT assay on the PC3 cell line.
Results: In this research, mean diameter of the drug-containing nanoarchaeosomes was estimated at 263 nm using the ZetaSizer device. Moreover, drug loading efficiency of nanoarchaeosomes was estimated at 98%. Furthermore, the toxicity of the free and nanoarchaeosome drugs was assessed via the MTT assay, results of which were indicative of a mean of IC 50 0.22 µg/ml in this regard.
Conclusion: According to the results of the study, archaeosomes extracted from polar lipids were produced with high concentration and purity on the nanoscale. Considering the high stability, ease of production, level of drug loading, and toxic effect on cancer cells, nanoarchaeosomes can be used as a suitable technique for targeted drug delivery in future studies.
Methods: Halobacterium salinarum bacteria were cultured in HS medium, and their polar lipids of the membrane were removed applying the Blight&Dye technique in order to obtain nanoarchaeosome containing membrane polar lipids. In the next stage, nanoarchaeosomes were prepared by the hydration of polar lipids. In addition, cell viability was evaluated using the MTT assay on the PC3 cell line.
Results: In this research, mean diameter of the drug-containing nanoarchaeosomes was estimated at 263 nm using the ZetaSizer device. Moreover, drug loading efficiency of nanoarchaeosomes was estimated at 98%. Furthermore, the toxicity of the free and nanoarchaeosome drugs was assessed via the MTT assay, results of which were indicative of a mean of IC 50 0.22 µg/ml in this regard.
Conclusion: According to the results of the study, archaeosomes extracted from polar lipids were produced with high concentration and purity on the nanoscale. Considering the high stability, ease of production, level of drug loading, and toxic effect on cancer cells, nanoarchaeosomes can be used as a suitable technique for targeted drug delivery in future studies.
Type of Article: Original article |
Subject:
Basic Medical Sciences
Received: 2018/04/23 | Accepted: 2018/08/19 | Published: 2018/08/20
Received: 2018/04/23 | Accepted: 2018/08/19 | Published: 2018/08/20
References
1. Jemal, A., et al., Cancer statistics, 2008. CA: a cancer journal for clinicians, 2008. 58(2): 71-96. [DOI:10.3322/CA.2007.0010]
2. Machtay, M., et al., Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. International Journal of Radiation Oncology* Biology* Physics, 2012. 82(1): 425-434. [DOI:10.1016/j.ijrobp.2010.09.004]
3. Pollack, J.R., et al., Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature genetics, 1999. 23(1): 41. [DOI:10.1038/12640]
4. Jin, G.-H., et al., A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and VMAT. Radiation Oncology, 2013. 8(1): 89. [DOI:10.1186/1748-717X-8-89]
5. Waxman J. Gonadotrophin hormone releasing analogues open new doors in cancer treatment. British medical journal (Clinical research ed.), 1987. 295(6606): 1084. [DOI:10.1136/bmj.295.6606.1084]
6. Krishnan, L., et al., Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infection and immunity, 2000. 68(1): 54-63. [DOI:10.1128/IAI.68.1.54-63.2000]
7. Haley, B. and E. Frenkel. Nanoparticles for drug delivery in cancer treatment. In Urologic Oncology: Seminars and original investigations. 2008. Elsevier. [DOI:10.1016/j.urolonc.2007.03.015]
8. Choquet, C., et al., Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. Applied microbiology and biotechnology, 1994. 42(2-3): 375-384. [DOI:10.1007/BF00902745]
9. Shi, J., et al., Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano letters, 2010. 10(9): 3223-3230. [DOI:10.1021/nl102184c]
10. Hu, C.-M.J., S. Aryal, and L. Zhang, Nanoparticle-assisted combination therapies for effective cancer treatment. Therapeutic delivery, 2010. 1(2): 323-334. [DOI:10.4155/tde.10.13]
11. González-Paredes, A., etal, Delivery systems for natural antioxidant compounds: Archaeosomes and archaeosomal hydrogels characterization and release study. International journal of pharmaceutics, 2011. 421(2): 321-331. [DOI:10.1016/j.ijpharm.2011.09.042]
12. Oesterhelt, D. and W. Stoeckenius, [69] Isolation of the cell membrane of Halobacterium halobium and its fractionation into red and purple membrane, in Methods in enzymology. 1974, Elsevier. 667-678. [DOI:10.1016/0076-6879(74)31072-5]
13. Dawson, K.S., K.H. Freeman, and J.L. Macalady, Molecular characterization of core lipids from halophilic archaea grown under different salinity conditions. Organic geochemistry, 2012. 48: 1-8. [DOI:10.1016/j.orggeochem.2012.04.003]
14. Sprott, G.D., G.B. Patel, and L. Krishnan, Archaeobacterial ether lipid liposomes as vaccine adjuvants, in Methods in enzymology. 2003, Elsevier. 155-172. [DOI:10.1016/S0076-6879(03)73011-0]
15. Ferrante, G., J.C. Richards, and G.D. Sprott, Structures of polar lipids from the thermophilic, deep-sea archaeohacterium Methanococcus jannaschii. Biochemistry and Cell Biology, 1990. 68(1): 274-283. [DOI:10.1139/o90-038]
16. Bligh, E.G. and W.J. Dyer, A rapid method of total lipid extraction and purification. Canadian journal of biochemistry and physiology, 1959. 37(8): 911-917. [DOI:10.1139/o59-099]
17. Attar, A., et al., The potential of archaeosomes as carriers of pDNA into mammalian cells. Artificial cells, nanomedicine, and biotechnology, 2016. 44(2): 710-716. [DOI:10.3109/21691401.2014.982800]
18. Gao, X., et al., Diagnostic and prognostic markers for human prostate cancer. The prostate, 1997. 31(4): 264-281.
https://doi.org/10.1002/(SICI)1097-0045(19970601)31:4<264::AID-PROS8>3.0.CO;2-K [DOI:10.1002/(SICI)1097-0045(19970601)31:43.0.CO;2-K]
19. Touma, N.J., J.I. Izawa, and J.L. Chin, Current status of local salvage therapies following radiation failure for prostate cancer. The Journal of urology, 2005. 173(2): 373-379. [DOI:10.1097/01.ju.0000150627.68410.4d]
20. Heyns, C., et al., Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer. BJU international, 2003. 92(3): 226-231. [DOI:10.1046/j.1464-410X.2003.04308.x]
21. Morgan, K., et al., Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo. Cancer Research, 2008. 68(15): 6331-6340. [DOI:10.1158/0008-5472.CAN-08-0197]
22. ŠTĚPÁN, J.J., et al., Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. The Journal of Clinical Endocrinology & Metabolism, 1989. 69(3): 523-527. [DOI:10.1210/jcem-69-3-523]
23. Orwoll, E.S., et al., The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med, 1990. 112(1): 29-34. [DOI:10.7326/0003-4819-112-1-29]
24. Peer, D., et al., Nanocarriers as an emerging platform for cancer therapy. Nature nanotechnology, 2007. 2(12): 751. [DOI:10.1038/nnano.2007.387]
25. Grit, M. and D.J. Crommelin, Chemical stability of liposomes: implications for their physical stability. Chemistry and physics of lipids, 1993. 64(1-3): 3-18. [DOI:10.1016/0009-3084(93)90053-6]
26. Koga, Y. and H. Morii, Recent advances in structural research on ether lipids from archaea including comparative and physiological aspects. Bioscience, biotechnology, and Biochemistry, 2005. 69(11): 2019-2034. [DOI:10.1271/bbb.69.2019]
27. González-Paredes, A., et al., Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study. Journal of liposome research, 2010. 20(4): 269-276. [DOI:10.3109/08982100903402962]
28. Li, Z., et al., Investigation of archaeosomes as carriers for oral delivery of peptides. Biochemical and biophysical research communications, 2010. 394(2): 412-417. [DOI:10.1016/j.bbrc.2010.03.041]
29. Vakilzadeh, H., J. Varshosaz, and M. Minaiyan, Pulmonary Delivery of Triptorelin Loaded in Pluronic Based Nanomicelles in Rat Model. Current drug delivery, 2018. 15(5): 630-640. [DOI:10.2174/1567201815666180209113735]
30. Patel, S., et al., Development and evaluation of liposomes for topical delivery of tacrolimus (Fk-506). Journal of Scientific Research, 2010. 2(3): 585. [DOI:10.3329/jsr.v2i3.3258]
31. Bhatia, A., R. Kumar, and O.P. Katare, Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci, 2004. 7(2): 252-259.
32. Réthoré, G., et al., Archaeosomes based on synthetic tetraether-like lipids as novel versatile gene delivery systems. Chemical Communications, 2007(20): 2054-2056. [DOI:10.1039/B618568A]
33. Moghimipour, E., et al., Archaeosome made from lipids extracted of Acidianus brierleyi as a new drug delivery system. Journal of Pure and Applied Microbiology, 2014. 8(2): 957-964.
34. Ahmadi, L., et al., to evaluate the effect of formulation of nano archaeosomal 6-gingerol on the growth of breast cancer MCF-7 cell line. 2015.
35. Sharifat Salmani, A., et al., Preparation of Archaeosome Adjuvant from membrane Polar lipids of large scale cultured Methanobreveibacter smithii. New Cellular and Molecular Biotechnology Journal, 2014. 4(15): 51-59.
36. Karimi, H., et al., Application of Archaeosome Nanoparticles as a DNA Vaccine Delivery System and Evaluation of its Effect in a C57BL/6 Tumor Model. Pathobiology Research, 2017. 19(4): 71-85.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
